Johanna Godoy, DPM
Foot & Ankle Surgery · Wayne, NJNPI 1528220084
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $189,650 of the $253,608 with a category attached, or 74.8%. Stryker accounts for 85.4% of it on its own, with 38 other manufacturers making up the rest. Reporting peaked in 2023 at $84,645 and has fallen 58.7% since, to $34,968 in 2025. Among foot & ankle surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 488 payments — averaging $519.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$217K
- DNE LLC$13K
- Seapearl East, Inc$6K
- Paragon 28, Inc.$6K
- Kerecis Limited$4K
- Arthrex$4K
- plus $5K from 33 others
What the payments were for
- Consulting fees$189,65075%
- Travel & lodging$38,34015%
- Food & beverage$19,1948%
- Education$6,4243%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 291 | $216,572 |
| DNE LLC | 4 | $12,642 |
| Seapearl East, Inc | 15 | $6,188 |
| Paragon 28, Inc. | 33 | $5,889 |
| Kerecis Limited | 9 | $3,510 |
| Arthrex | 30 | $3,500 |
| Orthofix Medical, Inc. | 13 | $1,140 |
| Integra Lifesciences Corporation | 17 | $661 |
| Treace Medical Concepts, Inc. | 6 | $544 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 11 | $394 |
| Acera Surgical, Inc. | 3 | $389 |
| Smith+Nephew | 9 | $276 |
| Abbott | 3 | $213 |
| Inari Medical, Inc. | 1 | $195 |
| Novastep Inc. | 2 | $161 |
| Extremity Medical | 2 | $158 |
| Suvon Surgical LLC | 1 | $132 |
| Zimmer Biomet | 4 | $126 |
| Innovation Technologies Inc | 1 | $118 |
| DJO, LLC | 2 | $110 |
| Medshape, Inc. | 3 | $85 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $81 |
| Cardiovascular Systems Inc. | 1 | $80 |
| Dynasplint Systems Inc. | 3 | $73 |
| Sebela Pharmaceuticals Inc. | 4 | $70 |
| Nevro Corp. | 2 | $43 |
| Convatec Inc. | 2 | $40 |
| TEI Medical Inc. | 2 | $27 |
| Organogenesis Inc. | 1 | $27 |
| Misonix Inc | 1 | $25 |
| Medtronic | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Zimvie Inc. | 1 | $18 |
| Trilliant Surgical LLC. | 1 | $18 |
| Bioventus LLC | 1 | $17 |
| Next Science LLC | 1 | $15 |
| Terumo BCT, Inc. | 1 | $15 |
| GRT US Holding, Inc. | 1 | $7 |
| Checkpoint Surgical, Inc | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HOFFMANN$109,958
- SALVATION$82,324
- PROstep$45,699
- PROPHECY$28,097
- T2$26,050
- INFINITY$16,260
- VARIAX$14,048
- INVISION$13,872
- SEAL$12,642
- ORTHOLOC 2 LAPIFUSE$12,340
- Kerecis Omega3 Marigen$11,921
- GRAVITY SYNCHFIX$11,625
- PROSTEP MICA$10,644
- FIXOS$10,500
- AUGMENT INJECTABLE$4,758
- Kerecis Omega3 SurgiClose$3,542
- AXSOS$3,161
- PRIME SERIES$2,107
- MONKEY RINGS$1,838
- BIO4$1,697
How this compares
$253,608 in reported general payments places this provider in the 95th percentile of 542 foot & ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 11 | $3,326 |
| CiclopiroxCiclopirox Olamine | 44 | $1,589 |
| Ammonium Lactate | 11 | $195 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $119 |
| Ibuprofen | 22 | $67 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $276 | $3,32611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 542 foot & ankle surgery providers in New Jersey.
Other foot & ankle surgery in Wayne
- Heidi GodoyWayne$43K
- Homam BadriWayne$13K
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$843K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Andrew BriefRidgewood$253K
- Mark SolomonCedar Knolls$232K
- Evan AdlerOld Bridge$195K
- Shane HollawellManasquan$169K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.